LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Barchitta, Martina ^a   Quattrocchi, Annalisa ^a   Maugeri, Andrea ^a   Vinciguerra, Manlio ^b,c   Agodi, Antonella ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CANCER RISK; COLORECTAL CANCER; DNA METHYLATION; EPIGENETICS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; HUMAN; LIVER CELL CARCINOMA; LONG INTERSPERSED NUCLEOTIDE ELEMENT 1; LONG INTERSPERSED REPEAT; STOMACH CANCER; SYSTEMATIC REVIEW; BLOOD; GENETIC EPIGENESIS; GENETICS; META ANALYSIS; NEOPLASM; RISK;

TUMOR MARKER;

BIOMARKERS, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; NEOPLASMS; RISK;

EID: 84907500719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109478     Document Type: Article

References (69)

1. Cash H, Tao L, Yuan J.M., Marsit C., Houseman E, et al. (2012) LINE-1 hypomethylation is associated with bladder cancer risk among non-smoking Chinese. Int J Cancer 130: 1151-1159.
2. Laird PW, Jaenisch R. (1994) DNA methylation and cancer. Hum Mol Genet 3: 1487-1496.
3. Jones PA (1996) DNA methylation errors and cancer. Cancer Res 56: 2463-2467.
4. Liu L, Wylie RC, Andrews L.G., Tollefsbol T.O. (2003) Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124: 989-998.
5. Davis CD, Uthus E.O. (2004) DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med 229: 988-995.
6. Chen RZ, Pettersson U, Beard C., Jackson-Grusby L, Jaenisch R. (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395: 89-93.
7. Lander ES, Linton LM, Birren B, Nusbaum C., Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
8. Rodriguez J, Frigola J, Vendrell E., Risques RA, Fraga MF, et al. (2006) Chromosomal instability correlates with genomewide DNA demethylation in human primary colorectal cancers. Cancer Res 66: 8462-9468.
9. Agnelli L, Bicciato S, Mattioli M., Fabris S, Intini D, et al (2005) Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol 23: 7296-7306.
10. Fabris S, Ronchetti D, Agnelli L., Baldini L, Morabito F, et al (2007) Transcriptional features of multiple myeloma patients with chromosome 1q gain. Leukemia, 21: 1113-1116.
11. Woo HD, Kim J. (2012) Global DNA Hypomethylation in Peripheral Blood Leukocytes as a Biomarker for Cancer Risk: A Meta-Analysis. PLoS ONE 7:e34615.
12. Hsiung D, Marsit C, Houseman E., Eddy K, Furniss C, et al (2007) Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 16: 108-114.
13. Zhu ZZ, Sparrow D, Hou L., Tarantini L, Bollati V, et al (2011) Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 22: 437-447.
14. Wilhelm C, Kelsey K, Butler R., Plaza S, Gagne L, et al (2010) Implications of LINE1 Methylation for Bladder Cancer Risk in Women. Clin Cancer Res 16: 1682-1689.
15. Baba Y, Huttenhower C, Nosho K., Tanaka N, Shina K, et al (2010) Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Molecular Cancer 9: 125.
16. Brennan K, Flanagan J.M. (2012) Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 5: 1345-1357.
17. Moher D, Liberati A, Tetzlaff J., Altman DG, PRISMA Group (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8: 336-341.
18. Higgins J, Thompson SG, Deeks J.J., Altman D.G. (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
19. Higgins JP, Thompson S.G. (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
20. Higgins JPT, Green S. (2008) Cochrane handbook for systematic reviews of interventions Version 5.0.0 updated February 2008. The Cochrane Collaboration.
21. Ogino S, Nosho K, Kirkner G.J., Kawasaki T., Chan AT, et al. (2012) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100: 1734-1738.
22. Sigalotti L, Fratta E, Bidoli E., Covre A, Parisi G, et al (2011) Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. J Transl Med 9: 78.
23. Bae JM, Shin SH, Kwon H.J., Park SY, Kook M, et al. (2012) ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int J Cancer 131: 1323-1331.
24. Van Hoesel A., van de Velde C, Kuppen P, Liefers G, Putter H, et al. (2012) Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. Breast Cancer Res Treat 134: 1103-1114.
25. Gao XD, Qu JH, Chang X.J., Lu YY, Bai WL, et al. (2013) Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma. Liver Int 34: 136-146.
26. Iwagami S, Baba Y, Watanabe M., Shigaki H, Miyake K, et al (2013) LINE-1 Hypomethylation Is Associated With a Poor Prognosis Among Patients With Curatively Resected Esophageal Squamous Cell Carcinoma. Ann Surg 257(3): 449-55.
27. Shigaki H, Baba Y, Watanabe M., Murata A, Iwagami S, et al (2013) LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer 16: 480-487.
28. Antelo M, Balaguer F, Shia J., Shen Y, Hur K, et al (2012) A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer. PLoS ONE 7: e45357.
29. Estecio MRH, Gharibyan V, Shen L., Ibrahim AEK, Doshi K, et al (2007) LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability. PLoS ONE 2:e399.
30. Hur K, Cejas P, Feliu J., Moreno-Rubio J, Burgos E, et al (2014) Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of protooncogenes in human colorectal cancer metastasis. Gut 63: 635-646.
31. Matsunoki A, Kawakami K, Kotake M., Kaneko M, Kitamura H, et al (2012) LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer. BMC Cancer 12: 574.
32. Pavicic W, Joensuu E, Nieminen T., Peltomäki P (2012) LINE-1 hypomethylation in familial and sporadic cancer. J Mol Med 90: 827-835.
33. Sunami E, de Maat M, Vu A, Turner R.R., Hoon DSB (2011) LINE-1 Hypomethylation During Primary Colon Cancer Progression. PLoS ONE 6(4): e18884.
34. Chalitchagorn K, Shuangshoti S, Hourpai N., Kongruttanachok N, Tangkijvanich P, et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23: 8841-8846.
35. Hou L, Wang H, Sartori S., Gawron A, Lissowska J, et al (2010) Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer 127: 1866-1874.
36. Gao Y, Baccarelli A, Shu X.O., Ji BT, Yu K, et al. (2012) Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study. Br J Cancer 106: 585-391.
37. Lee JR, Chung WC, Kim J.D., Lee KM, Paik CN, et al. (2011) Differential LINE-1 Hypomethylation of Gastric Low-Grade Dysplasia from High Grade Dysplasia and Intramucosal Cancer. Gut Liver 5: 149-153.
38. Ramzy I, Omran D, Hamad O., Shaker O, Abboud A. (2011) Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma. Arab J Gastroenterol 12: 139-142.
39. Wu HC, Wang Q, Yang H.I., Tsai WY, Chen CJ, et al. (2012) Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis 33: 1340-1345.
40. Tangkijvanich P, Hourpai N, Rattanatanyong P., Wisedopas N, Mahachai V, et al (2007) Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clin Chim Acta 379: 127-133.
41. Di JZ, Han XD, Gu W.Y., Wang Y., Zheng Q, et al. (2011) Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. J Zhejiang Univ-Sci B 12: 805-811.
42. Kreimer U, Schulz WA, Koch A, Niegisch G., Goering W. (2013) HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma. Frontiers in Oncology 3: 255.
43. Wolff EM, Byun HM, Han H.F., Sharma S., Nichols PW, et al. (2010) Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer. PLoS Genet 6:e1000917.
44. Subbalekha K, Pimkhaokham A, Pavasant P., Chindavijak S, Phokaew C, et al (2009) Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients. Oral Oncol 45: 184-191.
45. Phokaew C, Kowudtitham S, Subbalekha K., Shuangshoti S, Mutirangura A. (2008) LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic Acids Res 36: 5704-5712.
46. Pobsook T, Subbalekha K, Sannikorn P., Mutirangura A. (2011) Improved measurement of LINE-1 sequence methylation for cancer detection. Clin Chim Acta 412; 314-321.
47. Daskalos A, Nikolaidis G, Xinarianos G., Savvari P, Cassidy A, et al (2009) Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 124: 81-87.
48. Saito K, Kawakami K, Matsumoto I., Oda M, Watanabe G, et al (2010) Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non-Small Cell Lung Cancer. Clin Cancer Res 16: 2418-2426.
49. Choi JY, James S, Link P., McCann S, Hong C, et al (2009) Association between global DNA hypomethylation in leukocytes and risk of breast Cancer. Carcinogenesis 30: 1889-1897.
50. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, et al (2011) LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer. PLoS ONE 6:e27361.
51. Yegnasubramanian S, Haffner M, Zhang Y., Gurel B, Cornish TC, et al (2008) DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity. Cancer Res 68: 8954-67.
52. Choi IS, Estecio M, Nagano Y., Kim DH, White J, et al. (2007) Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Modern Pathology 20: 802-810.
53. Dammann RH, Kirsch S, Schagdarsurengin U., Dansranjavin T, Gradhand E, et al (2010) Frequent aberrant methylation of the imprinted IGF2/H19locus and LINE1 hypomethylation in ovarian carcinoma. Int J Oncol 36: 171-179.
54. Lee JJ, Geli J, Larsson C., Wallin G, Karimi M, et al (2008) Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer. Int J Oncol 33: 861-869.
55. Shuangshoti S, Hourpai N, Pumsuk U., Mutirangura A. (2007) Line-1 Hypomethylation in Multistage Carcinogenesis of the Uterine Cervix. Asian Pac J Cancer Prev 8: 307-309.
56. Mirabello L, Savage S, Korde L., Gadalla SM, Greene M.H. (2010) LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet 11: 77.
57. Fabris S, Bollati V, Agnelli L., Morabito F, Motta V, et al (2011) Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6: 188-194.
58. Bollati V, Fabris S, Pegoraro V., Ronchetti D, Mosca L, et al (2009) Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis 30: 1330-1335.
59. Geli J, Kiss N, Karimi M., Lee JJ, Backdahl M, et al. (2008) Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior. Clin Cancer Res 14: 2551-2559.
60. Trankenschuh W, Puls F, Christgen M., Albat C, Heim A, et al (2010) Frequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver. PLoS ONE 5: e13688.
61. Igarashi S, Suzuki H, Niinuma T., Shimizu H, Nojima M, et al (2010) Novel Correlation between LINE-1 Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors. Clin Cancer Res 16: 5114-5123.
62. Feinberg AP, Vogelstein B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
63. Zhu ZZ, Hou L, Bollati V., Tarantini L, Marinelli B, et al (2010) Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 41: 126-139.
64. Piyathilake CJ, Macaluso M, Alvarez R.D., Chen M., Badiga S, et al. (2011) A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasia. Nutrition 27: 513-59.
65. van Bemmel D., Lenz P, Liao L.M., Baris D., Sternberg LR, et al. (2012) Correlation of LINE-1 methylation levels in patient matched buffy coat, serum, buccal cell and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev 21: 1143-1148.
66. Suter CM, Martin DI, Ward R.L. (2004) Hypomethylation of L1 retro-transposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 19: 95-101.
67. Rakyan VK, Down TA, Balding D.J., Beck S. (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12: 529-541.
68. Beck S, Rakyan V.K. (2008) The methylome: approaches for global DNA methylation profiling. Trends Genet 24: 231-237.
69. Nelson H, Marsit C, Kelsey K. (2011) Global Methylation in Exposure Biology and Translational Medical Science. Environ Health Perspect 119: 1528-1533.